This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Marpai, Inc.
8/8/2024
Good morning and welcome to the MARPEC second quarter 2024 earnings conference call. All participants will be in the listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. Please note this event is being recorded. I would now like to turn the conference over to Steve Johnson, Chief Financial Officer. Please go ahead.
Good morning and welcome to the MARPEI second quarter 2024 earnings release webcast. With me this morning is Damian Lamandola, CEO and Director of MARPEI. If you turn your attention to the slide is that we have our required safe harbor and forward-looking statement disclosure.
Hello. Since I became CEO, our team has worked tirelessly on MARPEI's turnaround. As many of you know, I've invested not only my time, but millions of dollars into our company. I have never been more committed to our company and our stakeholders. This commitment stems from what we see in the TPA marketplace, our new leadership, and our employees' commitment to turning Marpay into a positive cash flow company. Our focus has been on profitably growing the company and achieving positive cash flow, which is beginning to manifest in our financial results, including significantly cutting costs right-sizing our balance sheet, and improving our cash from operations. I'm highly encouraged by our improvements. Our sales team has done a great job of repositioning Marpay to new and existing customers. I remind you that our total addressable market is $22 billion and growing. I will now turn the call back to Steve to discuss our financial results.
Thanks, Damien. We filed our 10-Q yesterday after the market closed, along with the earnings release, and I would invite you to review the details in those documents. I will briefly cover some highlights of the following achievements year to date. While revenue declined by 28% year over year, we cut cash operating expense by 38%, saving approximately $4 million. Our cash operating loss was reduced from approximately $7.3 million to approximately $4.7 million for the second quarter. As Damien alluded to, we right-sized our balance sheet by selling non-core assets, adjusting assets to the current fair value, as well as extending the maturity of our net debt. These changes will provide resources for growth and make future investment yields a higher return on capital. As a result of our turnaround plan, our cash used in operations improved by approximately $2.3 million in the second quarter of 2024 versus the second quarter of 2023, leading to a net cash increase of approximately 0.6 million in the second quarter of 2024, which is a decrease of the cash in the second quarter of 2023 of approximately 2.3 million. Again, in the second quarter of 2024, We had a net cash increase of $600,000, up from the previous year's decrease in cash of $2.3 million. I would now like to turn it back over to Damian.
Thank you. Marpay is all about saving enterprises of all sizes significant money in managing employees' health care costs. As I mentioned earlier, it is a $22 billion industry and growing. Our company is undergoing substantial changes that point to growth and positive cash flow. My commitment to all stakeholders has never been stronger. One area I'm not happy with is our stock price. I believe we are horribly undervalued. As the turnaround unfolds and we continue to improve our financial metrics and we continue to grow our market presence, I believe the financial markets will take notice. Thank you for your time today. I remain committed and excited to be leading your company. Thank you for your continued confidence and support.
Thank you, Damian. This completes Marpay's second quarter 2024 earnings call. If you have questions or require further information, please see the information on the screen or go to our investor relations website. This webcast will be available for replay. Thank you again for joining us this morning.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.